Pre-exposure prophylaxis (PrEP) uptake and service delivery adaptations during the first wave of the COVID-19 pandemic in 21 PEPFAR-funded countries

Background Mitigation measures for the first wave of the COVID-19 pandemic and burden on health systems created challenges for pre-exposure prophylaxis (PrEP) service delivery. We examined PrEP uptake in PEPFAR programs before and after the start of the COVID-19 pandemic. Methods We studied two PEPFAR program monitoring indicators, using routine Monitoring, Evaluation, Reporting (MER) indicators capturing uptake of PrEP (PrEP_NEW) and overall use of PrEP (PrEP_CURR). We also analyzed descriptive program narratives to understand successes and challenges field teams encountered after the start of the COVID-19 pandemic. To assess changes in coverage of PrEP across 21 countries, we calculated the “PrEP to need ratio” (PnR) using a published methodology. We defined the pre-COVID time period as April 1, 2019 –March 31, 2020 and the COVID time period as April 1, 2020 –March 31, 2021. Findings The total number of persons who initiated PrEP increased by 157% from 233,250 in the pre-COVID-19 period compared with 599,935 in the COVID-19 period. All countries, except five, noted significant increases in PrEP uptake. PrEP uptake among adolescent girls and young women (AGYW) increased by 159% from 80,452 AGYW in the pre-COVID-19 period to 208,607 AGYW in the COVID-19 period. There were 77,430 key populations (KP) initiated on PrEP in the pre-COVID-19 period and 209,114 KP initiated in the COVID-19 period (a 170% increase). The PnR increased 214% in the COVID-19 period across all PEPFAR-supported countries. Adaptations, such as multi-month dispensing (MMD) of PrEP; virtual demand creation activities; decentralized, community-based and virtual service delivery, were implemented to maintain PrEP services. Conclusions PEPFAR programs continued to maintain and initiate new clients on PrEP despite the challenges posed by the COVID-19 pandemic. Adaptations such as MMD of PrEP and use of technology were vital in expanding service delivery and increasing PrEP coverage. Funding This project has been supported by the U.S. President’s Emergency Plan for AIDS Relief.

[1]  D. Bangsberg,et al.  Understanding Repeat Positive HIV Testing in South Africa Under Changing Treatment Guidelines , 2021, AIDS and Behavior.

[2]  G. Siberry,et al.  The impact of COVID‐19 on multi‐month dispensing (MMD) policies for antiretroviral therapy (ART) and MMD uptake in 21 PEPFAR‐supported countries: a multi‐country analysis , 2021, Journal of the International AIDS Society.

[3]  S. Odafe,et al.  Expanding access to HIV services during the COVID-19 pandemic—Nigeria, 2020 , 2021, AIDS Research and Therapy.

[4]  N. Spicer,et al.  Dispensing antiretrovirals during Covid-19 lockdown: re-discovering community-based ART delivery models in Uganda , 2021, BMC Health Services Research.

[5]  F. Lule,et al.  Adoption of guidelines on and use of oral pre-exposure prophylaxis: a global summary and forecasting study , 2021, The lancet. HIV.

[6]  R. Walensky,et al.  SARS-CoV-2 Variants of Concern in the United States-Challenges and Opportunities. , 2021, JAMA.

[7]  R. Glaubius,et al.  Potential effects of disruption to HIV programmes in sub-Saharan Africa caused by COVID-19: results from multiple mathematical models , 2020, The lancet. HIV.

[8]  J. Bauermeister,et al.  A Systematic Review of Technology-Assisted HIV Testing Interventions , 2020, Current HIV/AIDS Reports.

[9]  Jeffrey Ferranti,et al.  Telehealth transformation: COVID-19 and the rise of virtual care , 2020, J. Am. Medical Informatics Assoc..

[10]  J. Justman,et al.  Progress toward HIV epidemic control in Lesotho. , 2019, AIDS.

[11]  J. Justman,et al.  Progress toward HIV epidemic control in lesotho: results from a population-based survey. , 2019, AIDS.

[12]  B. Kuehn.  Rwanda Celebrates Progress Toward HIV Control. , 2019, JAMA.

[13]  R. Chou,et al.  Preexposure Prophylaxis for the Prevention of HIV Infection: Evidence Report and Systematic Review for the US Preventive Services Task Force. , 2019, JAMA.

[14]  B. Wood,et al.  A Review of Telehealth Innovations for HIV Pre-Exposure Prophylaxis (PrEP) , 2019, Current HIV/AIDS Reports.

[15]  J. Saul,et al.  The DREAMS core package of interventions: A comprehensive approach to preventing HIV among adolescent girls and young women , 2018, PloS one.

[16]  Michael R. Kramer,et al.  The prevalence of pre-exposure prophylaxis use and the pre-exposure prophylaxis-to-need ratio in the fourth quarter of 2017, United States. , 2018, Annals of epidemiology.

[17]  R. Gandhi.  Preexposure Prophylaxis for the Prevention of HIV , 2018 .

[18]  R. Remien,et al.  “Testing, Testing”: Multiple HIV-Positive Tests among Patients Initiating Antiretroviral Therapy in Ethiopia , 2017, Journal of the International Association of Providers of AIDS Care.

[19]  Nitika Pant Pai,et al.  Do digital innovations for HIV and sexually transmitted infections work? Results from a systematic review (1996-2017) , 2017, BMJ Open.